Biotechnology and Development ApS: Financial statements 2022
CVR: 33870639
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
Biotechnology and Development ApS (CVR 33870639) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 44,587 and a net result of DKK 19,043 compared with DKK -22,155 the year before. Equity in the 2022 report amounted to DKK 55,373. The solvency ratio was 53.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 44,587
- Profit/Loss
- DKK 19,043
- Equity
- DKK 55,373
- Total Assets
- DKK 102,828
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 45 t. | 19 t. | 55 t. | 1 |
| 2021 | - | -7 t. | -22 t. | 36 t. | 1 |
| 2020 | - | 79 t. | 47 t. | 58 t. | 0 |
| 2019 | - | 19 t. | -8 t. | 12 t. | - |
| 2018 | - | 36 t. | 6 t. | 20 t. | 1 |
Official annual report
Keep an eye on Biotechnology and Development ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout Biotechnology and Development ApS
Biotechnology and Development ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 2011. The company is registered under the industry Engroshandel med andre råvarer og halvfabrikata. The management consists of Karl Erik Molbech. The company is owned by KLMC Holding ApS. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 282,184 and a net result of DKK -1,709 compared with DKK 66,166 the year before. Equity in the 2025 report amounted to DKK 105,217.